Synbionik designs and creates genetically modified microorganisms and matching bioreactor systems for the production of chemical compounds. This biosynthetic approach leads to drastic cost, purity and sustainability advantages over traditional production or extraction methods.
Synbionik fully embraces advanced laboratory automation technologies with the goal of realizing significant productivity advantages as one of the earliest fully committed adopters in Europe.
Synbionik was founded in early 2019. Its headquarter is in Frankfurt/Main, Germany.